Edition:
India

Mabion Updates Strategy Of Medicinal Product Development


Wednesday, 3 Apr 2019 

April 3 (Reuters) - Mabion SA ::UPDATES ITS STRATEGY OF MEDICINAL PRODUCT DEVELOPMENT.PLANS TO LAUNCH RESEARCH AND DEVELOPMENT WORKS ON BIOSIMILAR DRUGS IN FIELD OF AUTOIMMUNITY, METABOLIC DISEASES AND ONCOLOGY. 

Related Company News

Company Quote

83.9
-0.5 -0.59%
19 Jul 2019